Venus Remedies Limited (NSE:VENUSREM)

Market Cap	5.98B
Revenue (ttm)	6.48B
Net Income (ttm)	453.20M
Shares Out	n/a
EPS (ttm)	33.90
PE Ratio	13.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,613
Average Volume	153,939
Open	447.80
Previous Close	447.80
Day's Range	427.20 - 448.00
52-Week Range	270.25 - 476.90
Beta	0.62
RSI	78.33
Earnings Date	May 30, 2025

About Venus Remedies

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products. Venus Remedies Limi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 1,187
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VENUSREM

Financial Performance

In 2024, Venus Remedies's revenue was 6.48 billion, an increase of 7.72% compared to the previous year's 6.01 billion. Earnings were 453.20 million, an increase of 59.07%.